Ligand validation:7ZD9

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

NAD is a Ligand Of Interest in 7ZD9 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7ZD9_NAD_C_502	97%	66%	0.066	0.982	0.56	0.73	-	1	2	0	100%	1
7ZD9_NAD_A_501	96%	66%	0.074	0.982	0.56	0.73	-	1	1	0	100%	1
7O5L_NAD_C_501	95%	67%	0.073	0.977	0.56	0.67	-	1	6	0	100%	1
7ZD7_NAD_C_503	92%	66%	0.092	0.984	0.57	0.71	-	1	1	0	100%	1
7O5M_NAD_C_501	78%	68%	0.118	0.961	0.55	0.65	-	1	2	0	100%	1
7ZD8_NAD_C_503	56%	66%	0.16	0.931	0.59	0.69	-	1	1	0	100%	1
4URF_NAD_A_1249	100%	45%	0.034	0.995	0.96	1.2	2	4	0	0	100%	1
2C5A_NAD_B_1374	100%	25%	0.039	0.992	1.34	1.84	6	7	1	0	100%	1
1HET_NAD_A_402	100%	11%	0.043	0.994	2.25	2.1	9	8	0	0	100%	0.9068
2JHF_NAD_B_403	100%	18%	0.04	0.99	2.08	1.62	11	5	2	0	100%	1
1HEU_NAD_B_402	100%	8%	0.043	0.993	2.5	2.41	13	11	0	0	100%	0.8886

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.